about
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EP...
Read More
13.05
0.06
(0.46%)
978.2K
XNAS Volume
High volume today
XNAS 04 Dec, 2025 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
DBV Tech (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..